(EPI) WisdomTree India Earnings - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US97717W4226

EPI: Indian Stocks

The WisdomTree India Earnings Fund (NYSE ARCA:EPI) is an exchange-traded fund that primarily invests in Indian companies that are profitable and accessible to foreign investors. The funds investment strategy is designed to track the performance of its underlying index, which is comprised of Indian companies that meet specific eligibility criteria.

The funds portfolio is heavily concentrated in Indian equities, with at least 95% of its assets invested in constituent securities of the index or investments with similar economic characteristics. This suggests that the funds performance is closely tied to the overall Indian economy and the profitability of its constituent companies.

From a technical analysis perspective, the funds price action indicates a bullish trend, with its short-term and long-term moving averages suggesting a positive momentum. The funds last price is $47.31, with a 20-day SMA of $46.44 and a 50-day SMA of $45.08, indicating a potential upward trajectory. Additionally, the funds ATR is 0.50, representing a 1.05% daily price movement, which is relatively stable.

Considering the funds AUM of $3.287 billion, it is a sizable investment vehicle with a significant presence in the Indian equity market. The funds non-diversified nature means that it may be more susceptible to market volatility, but it also allows for a more focused investment approach.

Based on the available technical and fundamental data, a forecast for EPI could be as follows: With the current bullish trend and positive momentum, we can expect EPI to continue its upward trajectory in the short term. If the funds price can break through the 52-week high of $50.69, it may be a sign of further bullishness, potentially targeting a new high. Conversely, a drop below the 50-day SMA of $45.08 could indicate a reversal in the trend. Therefore, a potential price target for EPI could be $52.50, representing a 10% increase from its current price.

Additional Sources for EPI ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

EPI ETF Overview

Market Cap in USD 3,283m
Category India Equity
TER 0.85%
IPO / Inception 2008-02-22

EPI ETF Ratings

Growth Rating 59.3
Fundamental -
Dividend Rating 20.1
Rel. Strength -13.3
Analysts -
Fair Price Momentum 48.83 USD
Fair Price DCF -

EPI Dividends

Dividend Yield 12m 0.26%
Yield on Cost 5y 0.65%
Annual Growth 5y -12.20%
Payout Consistency 89.2%
Payout Ratio %

EPI Growth Ratios

Growth Correlation 3m 87%
Growth Correlation 12m -70.7%
Growth Correlation 5y 88.2%
CAGR 5y 20.66%
CAGR/Max DD 5y 0.99
Sharpe Ratio 12m 0.76
Alpha -9.95
Beta 0.463
Volatility 13.40%
Current Volume 491k
Average Volume 20d 707.2k
What is the price of EPI shares?
As of June 28, 2025, the stock is trading at USD 47.52 with a total of 490,950 shares traded.
Over the past week, the price has changed by +3.57%, over one month by +2.30%, over three months by +8.12% and over the past year by -1.23%.
Is WisdomTree India Earnings a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, WisdomTree India Earnings (NYSE ARCA:EPI) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.28 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EPI is around 48.83 USD . This means that EPI is currently overvalued and has a potential downside of 2.76%.
Is EPI a buy, sell or hold?
WisdomTree India Earnings has no consensus analysts rating.
What are the forecasts for EPI share price target?
According to our own proprietary Forecast Model, EPI WisdomTree India Earnings will be worth about 54.5 in June 2026. The stock is currently trading at 47.52. This means that the stock has a potential upside of +14.58%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 54.5 14.6%